Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3413

1.

Medical abortion with mifepristone and vaginal misoprostol between 64 and 70days' gestation.

Hsia JK, Lohr PA, Taylor J, Creinin MD.

Contraception. 2019 May 15. pii: S0010-7824(19)30169-6. doi: 10.1016/j.contraception.2019.05.006. [Epub ahead of print]

PMID:
31102629
2.

Photorearrangement of Quinoline-Protected Dialkylanilines and the Photorelease of Aniline-Containing Biological Effectors.

Deodato D, Asad N, Dore TM.

J Org Chem. 2019 May 16. doi: 10.1021/acs.joc.9b01031. [Epub ahead of print]

PMID:
31095378
3.

Mitigating placental injuries through up-regulating DAF in experimental APS mice:new mechanism of progesterone.

Zhang Y, Jin S.

Clin Exp Immunol. 2019 May 15. doi: 10.1111/cei.13313. [Epub ahead of print]

PMID:
31091357
4.

Pathways to seeking medication abortion care: A qualitative research in Uttar Pradesh, India.

Srivastava A, Saxena M, Percher J, Diamond-Smith N.

PLoS One. 2019 May 13;14(5):e0216738. doi: 10.1371/journal.pone.0216738. eCollection 2019.

5.

MIFEPRISTONE TREATMENT FOR MILD AUTONOMOUS CORTISOL SECRETION DUE TO ADRENAL ADENOMAS: A PILOT STUDY.

Belokovskaya R, Ravikumar A, Arumugam D, Izadmehr S, Goddard GM, Geer EB, Levine AC.

Endocr Pract. 2019 May 9. doi: 10.4158/EP-2019-0047. [Epub ahead of print]

PMID:
31070948
6.

Snapshot of medication abortion provision in the primary health care setting of regional and rural Victoria.

de Moel-Mandel C, Graham M, Taket A.

Aust J Rural Health. 2019 May 9. doi: 10.1111/ajr.12510. [Epub ahead of print]

PMID:
31070843
7.

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy.

Shah D, Rijal P, Thakur A, Rai R.

JNMA J Nepal Med Assoc. 2018 Sep-Oct;56(213):856-860.

PMID:
31065120
8.

Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies.

Gelfo V, Pontis F, Mazzeschi M, Sgarzi M, Mazzarini M, Solmi R, D'Uva G, Lauriola M.

J Clin Med. 2019 May 1;8(5). pii: E600. doi: 10.3390/jcm8050600.

9.

A new role for RU486 (mifepristone): it protects sperm from premature capacitation during cryopreservation in buffalo.

Dalal J, Kumar P, Chandolia RK, Pawaria S, Rajendran R, Sheoran S, Andonissamy J, Kumar D.

Sci Rep. 2019 Apr 30;9(1):6712. doi: 10.1038/s41598-019-43038-4.

10.

[Effects of Yun Kang oral liquid on rats model of embryo implantation disorder].

Zheng X, Guo LF, Dai MZ, Lyu GY, Chen SH.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2018 Jun 8;34(6):543-547. doi: 10.12047/j.cjap.5687.2018.121. Chinese.

PMID:
31032590
11.

Progesterone induces the release of bull spermatozoa from oviductal epithelial cells.

Romero-Aguirregomezcorta J, Cronin S, Donnellan E, Fair S.

Reprod Fertil Dev. 2019 Aug 29. doi: 10.1071/RD18316. [Epub ahead of print]

PMID:
31030724
12.

Current barriers, facilitators and future improvements to advance quality of abortion care: views of women.

Smith JL, Cameron S.

BMJ Sex Reprod Health. 2019 Apr 26. pii: bmjsrh-2018-200264. doi: 10.1136/bmjsrh-2018-200264. [Epub ahead of print]

PMID:
31028169
13.

Generation of Inducible Gene-Switched GAL4 Expressed in the Drosophila Female Germline Stem Cell Niche.

Ke YT, Hsu HJ.

G3 (Bethesda). 2019 Apr 24. pii: g3.400246.2019. doi: 10.1534/g3.119.400246. [Epub ahead of print]

14.

Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling.

Ritch SJ, Brandhagen BN, Goyeneche AA, Telleria CM.

BMC Cancer. 2019 Apr 24;19(1):376. doi: 10.1186/s12885-019-5587-3.

15.

Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.

Warden S, Genkin I, Hum S, Dunn S.

J Obstet Gynaecol Can. 2019 May;41(5):647-652. doi: 10.1016/j.jogc.2018.05.030. Epub 2018 Oct 26.

PMID:
31007171
16.

Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.

Norman WV, Munro S, Brooks M, Devane C, Guilbert E, Renner R, Kendall T, Soon JA, Waddington A, Wagner MS, Dunn S.

BMJ Open. 2019 Apr 20;9(4):e028443. doi: 10.1136/bmjopen-2018-028443.

17.

Adjunctive Agents for Cervical Preparation in Second Trimester Surgical Abortion.

Ralph JA, Shulman LP.

Adv Ther. 2019 Apr 19. doi: 10.1007/s12325-019-00953-2. [Epub ahead of print] Review.

PMID:
31004327
18.

Abortion Providers' experiences and views on self-managed medication abortion, an exploratory study.

Kerestes CA, Stockdale CK, Zimmerman MB, Hardy-Fairbanks AJ.

Contraception. 2019 Apr 16. pii: S0010-7824(19)30143-X. doi: 10.1016/j.contraception.2019.04.006. [Epub ahead of print]

PMID:
31002777
19.

Glucocorticoid-dependent expression of IAP participates in the protection against TNF-mediated cytotoxicity in MCF7 cells.

Mitre-Aguilar IB, Barrios-Garcia T, Ruiz-Lopez VM, Cabrera-Quintero AJ, Mejia-Dominguez NR, Ventura-Gallegos JL, Moreno-Mitre D, Aranda-Gutierrez A, Mejia-Rangel J, Escalona-Guzman AR, Chavarri-Guerra Y, Leon-Del-Rio A, Zentella-Dehesa A.

BMC Cancer. 2019 Apr 15;19(1):356. doi: 10.1186/s12885-019-5563-y.

20.

HAMPT, A Novel Quadruple Drug Combination Designed for Cancer Metastatic Chemoprevention: From Hypothesis to Proof-of-concept.

Xu H, Wan L, Xu J, Liu J, Zheng N, Jia L.

Curr Cancer Drug Targets. 2019;19(4):296-303. doi: 10.2174/1568009618666181001102557.

PMID:
30968769

Supplemental Content

Loading ...
Support Center